Compare NGS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGS | EOLS |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | 259 | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.6M | 550.9M |
| IPO Year | 2006 | 2018 |
| Metric | NGS | EOLS |
|---|---|---|
| Price | $37.97 | $8.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $40.67 | $15.50 |
| AVG Volume (30 Days) | 108.6K | ★ 933.3K |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | ★ 14.60 | 1.23 |
| EPS | ★ 0.83 | N/A |
| Revenue | $172,315,000.00 | ★ $297,176,000.00 |
| Revenue This Year | $15.05 | $13.27 |
| Revenue Next Year | $9.52 | $17.62 |
| P/E Ratio | $44.27 | ★ N/A |
| Revenue Growth | 9.94 | ★ 11.61 |
| 52 Week Low | $24.26 | $3.86 |
| 52 Week High | $44.61 | $8.43 |
| Indicator | NGS | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 71.95 |
| Support Level | $36.66 | $6.44 |
| Resistance Level | $40.34 | N/A |
| Average True Range (ATR) | 1.59 | 0.40 |
| MACD | 0.23 | 0.23 |
| Stochastic Oscillator | 97.72 | 88.38 |
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. It operates in one reporting segment. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.